Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Heart failure (CHF) guidelines recommend mineralocorticoid receptor antagonists for all symptomatic patients treated with a combination of ACE inhibitors/angiotensin receptor blockers (ARBs) and beta-blockers. As opposed to both eplerenone trials, patients in RALES (spironolactone) received almost n...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
07 June 2013
|
| In: |
European journal of clinical pharmacology
Year: 2013, Volume: 69, Issue: 10, Pages: 1747-1755 |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-013-1512-x |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-013-1512-x
|
| Author Notes: | L. Frankenstein, H.A. Katus, M. Grundtvig, T. Hole, J. de Blois, D. Schellberg, D. Atar, C. Zugck, S. Agewall, on behalf of the Norwegian Heart Failure Registry steering committee |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1756677018 | ||
| 003 | DE-627 | ||
| 005 | 20230426092553.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210430s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00228-013-1512-x |2 doi | |
| 035 | |a (DE-627)1756677018 | ||
| 035 | |a (DE-599)KXP1756677018 | ||
| 035 | |a (OCoLC)1341407461 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Frankenstein, Lutz |d 1973- |e VerfasserIn |0 (DE-588)124198937 |0 (DE-627)63440766X |0 (DE-576)328373281 |4 aut | |
| 245 | 1 | 0 | |a Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction |b a propensity score-matched cohort study |c L. Frankenstein, H.A. Katus, M. Grundtvig, T. Hole, J. de Blois, D. Schellberg, D. Atar, C. Zugck, S. Agewall, on behalf of the Norwegian Heart Failure Registry steering committee |
| 264 | 1 | |c 07 June 2013 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.04.2021 | ||
| 520 | |a Heart failure (CHF) guidelines recommend mineralocorticoid receptor antagonists for all symptomatic patients treated with a combination of ACE inhibitors/angiotensin receptor blockers (ARBs) and beta-blockers. As opposed to both eplerenone trials, patients in RALES (spironolactone) received almost no beta-blockers. Since pharmacological properties differ between eplerenone and spironolactone, the prognostic benefit of spironolactone added to this baseline combination therapy needs clarification. | ||
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Grundtvig, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hole, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Blois, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schellberg, Dieter |e VerfasserIn |0 (DE-588)1028373023 |0 (DE-627)730619974 |0 (DE-576)375906010 |4 aut | |
| 700 | 1 | |a Atar, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zugck, Christian |e VerfasserIn |0 (DE-588)1028371993 |0 (DE-627)730617548 |0 (DE-576)176412999 |4 aut | |
| 700 | 1 | |a Agewall, S. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of clinical pharmacology |d Berlin : Springer, 1968 |g 69(2013), 10, Seite 1747-1755 |h Online-Ressource |w (DE-627)253722829 |w (DE-600)1459058-X |w (DE-576)072372613 |x 1432-1041 |7 nnas |a Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction a propensity score-matched cohort study |
| 773 | 1 | 8 | |g volume:69 |g year:2013 |g number:10 |g pages:1747-1755 |g extent:9 |a Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction a propensity score-matched cohort study |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00228-013-1512-x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210430 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1028371993 |a Zugck, Christian |m 1028371993:Zugck, Christian |d 910000 |d 910100 |e 910000PZ1028371993 |e 910100PZ1028371993 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1028373023 |a Schellberg, Dieter |m 1028373023:Schellberg, Dieter |d 910000 |d 910100 |e 910000PS1028373023 |e 910100PS1028373023 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 124198937 |a Frankenstein, Lutz |m 124198937:Frankenstein, Lutz |d 910000 |d 910600 |e 910000PF124198937 |e 910600PF124198937 |k 0/910000/ |k 1/910000/910600/ |p 1 |x j | ||
| 999 | |a KXP-PPN1756677018 |e 3920377141 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"07 June 2013"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1756677018","title":[{"title":"Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction","title_sort":"Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction","subtitle":"a propensity score-matched cohort study"}],"name":{"displayForm":["L. Frankenstein, H.A. Katus, M. Grundtvig, T. Hole, J. de Blois, D. Schellberg, D. Atar, C. Zugck, S. Agewall, on behalf of the Norwegian Heart Failure Registry steering committee"]},"note":["Gesehen am 30.04.2021"],"physDesc":[{"extent":"9 S."}],"language":["eng"],"person":[{"given":"Lutz","family":"Frankenstein","role":"aut","display":"Frankenstein, Lutz"},{"role":"aut","display":"Katus, Hugo","family":"Katus","given":"Hugo"},{"display":"Grundtvig, M.","role":"aut","given":"M.","family":"Grundtvig"},{"role":"aut","display":"Hole, T.","given":"T.","family":"Hole"},{"family":"de Blois","given":"J.","display":"de Blois, J.","role":"aut"},{"role":"aut","display":"Schellberg, Dieter","given":"Dieter","family":"Schellberg"},{"given":"D.","family":"Atar","display":"Atar, D.","role":"aut"},{"family":"Zugck","given":"Christian","role":"aut","display":"Zugck, Christian"},{"family":"Agewall","given":"S.","display":"Agewall, S.","role":"aut"}],"id":{"eki":["1756677018"],"doi":["10.1007/s00228-013-1512-x"]},"relHost":[{"language":["eng"],"pubHistory":["1.1968/69 -"],"title":[{"title_sort":"European journal of clinical pharmacology","title":"European journal of clinical pharmacology"}],"id":{"eki":["253722829"],"zdb":["1459058-X"],"issn":["1432-1041"]},"name":{"displayForm":["organ of European Association for Clinical Pharmacology and Therapeutics (EACPT)"]},"note":["Gesehen am 11.10.05"],"titleAlt":[{"title":"Clinical pharmacology"},{"title":"EJCP"},{"title":"Pharmacologia clinica"}],"part":{"pages":"1747-1755","year":"2013","extent":"9","issue":"10","text":"69(2013), 10, Seite 1747-1755","volume":"69"},"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedDisp":"1968-","publisher":"Springer","dateIssuedKey":"1968"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction a propensity score-matched cohort studyEuropean journal of clinical pharmacology","recId":"253722829","type":{"bibl":"periodical","media":"Online-Ressource"}}]} | ||
| SRT | |a FRANKENSTEASSOCIATIO0720 | ||